In a small pilot study, researchers from North Carolina State University have demonstrated a rapid, simple way to generate large numbers of lung stem cells for use in disease treatment. This method of ...

Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent ...

(RTTNews) - MiNK Therapeutics (INKT), a clinical-stage company, said new translational data supporting the role of invariant natural killer T or iNKT cells in idiopathic pulmonary fibrosis or IPF were ...

A compound called orcinol glucoside, or OG for short, was found to reduce lung inflammation and scarring in mouse and cell ...

Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane ...

Medical Watch Digest for March 31 Potential treatment could clear scar tissue from lungs Scientists think they have ...

Panelists discuss how antifibrotic therapies for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) slow disease progression despite challenges with cost, tolerability, and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There are only three therapies for IPF approved by the ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety ...